Le Lézard
Classified in: Health, Science and technology
Subject: SVY

2018 Technology Innovations Enabling Precision Robotic Surgery: New Surgical Paradigm to Deliver Value across Markets


DUBLIN, Oct. 15, 2018 /PRNewswire/ --

The "Technology Innovations Enabling Precision Robotic Surgery" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This research service offers a strategic perspective of the customer, product, technology and competitors that are influencing the global market for surgical robotics. The report is split into three major sections, each focusing on industry overview, competitive landscape, and voice of stakeholder analysis. The report also includes sections for technology and product segmentation, examining the level the influence of technologies across various product portfolios.

The report features an exclusive section on designing the operating theatre of the future, which highlights some of the use cases of advanced technologies being adopted along with surgical robotic systems currently in use across leading healthcare facilities worldwide.

1. To strategically review the role played by NPD (new product development) and research and development (R&D) initiatives in improving the overall adoption of surgical robotics technologies
2. To analyze the ongoing shifts in healthcare needs which are largely driving R&D developments and technology-enabled business models of established and new participants.
3. Strategic investments, technical partnerships, distributor agreements, and IPOs in surgical robotics industry is increasing. What are the strategic priorities of existing/new participants in developing the global market?
4. In addition to the above, this research service also offers insights covering an independent review of industry strategies that are unbiased. This research service also provides details of key industry contacts who also participated in this research.

Key Topics Covered:

1. Executive Summary

2. Industry Overview & Dynamics

3. Competitive Overview & Landscape

4. Customer Segmentation & Adoption Levels

5. Product & Technology Analysis

6. Strategic Imperative - Redefining Value of Care

7. Summary of Analyst Insights

8. Global Patent Landscape

9. Key Industry Participants

For more information about this report visit https://www.researchandmarkets.com/research/lh3cjm/2018_technology?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....

at 16:54
Hondros College of Nursing (HCN) will introduce a new Medical Assisting program at its six Ohio campuses in 2024 to meet the growing need for medical assistants in a variety of settings.  According to the U.S. Bureau of Labor Statistics (BLS),...

at 16:45
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...



News published on and distributed by: